Insights On Drug Development

31. From Insights To Impact: Predictive Models And PAT For More Efficient And Robust Biologics Manufacturing 5/8/2026

    Explore how advanced scale-up methodologies and real-time analytical technologies strengthen both drug substance and drug product manufacturing by enabling process understanding and informed decision-making.

32. Spray Dried Biologics For Pulmonary Dosage Forms 5/8/2026

    View how spray drying enables stable, precisely engineered pulmonary powders for biologics, supporting efficient lung delivery, scalability, and preservation of molecular structure and activity.

33. The Analytical Advantage Across The Development Lifecycle 5/7/2026

    Integrated, regulatory‑ready analytics help accelerate development, strengthen submissions, and ensure consistent product quality throughout the pharmaceutical lifecycle.

34. Screening For Amorphous Drug Substance 5/6/2026

    Incorporate amorphous form screening early in development to unlock solubility advantages, improve bioavailability, and accelerate your path to market.

35. Precision By Design: Drug Innovation Through Structure-Based Drug Design (SBDD) 5/6/2026

    Leverage structure-based drug design to gain deeper molecular insights, prioritize high-potential candidates, and accelerate your path from discovery to clinic.

36. Integrating High-Content Imaging With Traditional Plate-Based Screening 5/6/2026

    Gain mechanistic insights beyond traditional viability assays, revealing nuanced cellular phenotypes and strengthening early drug discovery decisions without sacrificing throughput or efficiency.

37. Amorphous Solids: Implications For Solubility And Stability 5/6/2026

    Amorphous solids can enhance drug solubility and bioavailability but introduce stability risks, making careful characterization and control essential for successful pharmaceutical development and manufacturing.

38. Accelerating Small Molecule Protein Degrader Development Using High-Content Imaging 5/6/2026

    High‑content imaging enables rapid discovery and optimization of small‑molecule protein degraders by delivering multiparametric, single‑cell insights that accelerate hit identification, SAR development, and lead advancement.

39. Accelerating Discovery Success With Structure-Guided Drug Design 5/6/2026

    Structure‑enabled drug discovery revealed a novel, druggable binding site in Artemis, enabling rapid SAR optimization and a ~500‑fold potency improvement against a challenging oncology target.

40. Chirality In Drug Development: From Racemic Mixtures To Enantiopure Substances 5/6/2026

    Chiral crystallization enables efficient production of enantiopure drug substances, improving pharmacological control and safety while supporting scalable, cost‑effective small molecule development.